Danisco A/S: Alternative Energy Company Profile, SWOT & Financial Report

Document Sample
Danisco A/S: Alternative Energy Company Profile, SWOT & Financial Report Powered By Docstoc
					Danisco A-S

_________________________________________________________________________________



Danisco A/S                                                                     Financial Snapshot

                                                                                Operating Performance
Fast Facts
                                          Langebrogade 1, Copenhagen,           The company reported revenue of US$2,438.79
Headquarters Address
                                          1001,Denmark                          million during the fiscal year 2010 (2010). The
                                                                                company's revenue declined at a compounded rate of
Telephone                                 + 45 3 2662000
                                                                                8.77% during 2006–2010, with an annual growth of
                                                                                0.62% over 2009. In 2010, the company recorded an
Fax                                       + 45 3 2662175                        operating margin of 6.53%, as against 3.81% in 2009.

Website                                   www.danisco.com
                                                                                Revenue and Margins
Ticker Symbol, Stock Exchange             N/A

Number of Employees                       6,800

Fiscal Year End                           April

Revenue (in US$ million)                  2,438.79

Revenue (in DKK million)                  13,706.00




SWOT Analysis                                                                   Return on Equity

Strengths                                 Weaknesses                            The company recorded a return on equity (ROE) of
                                                                                3.84% for 2010, as compared to its peers,
Diversified product portfolio             Supplier dependency                   Novozymes A/S (Ticker: NZYM B), MGP Ingredients,
                                                                                Inc. (Ticker: MGPI) and Suedzucker AG (Ticker:
Strong research & development                                                   SZU), which recorded ROEs of 20.62%, 12.01% and
activities                                                                      7.66% respectively. The company reported an
                                                                                operating margin of 6.53% in 2010.
Wide geographical presence
                                                                                Return on Equity
Opportunities                             Threats

Increasing health consciousness           Fluctuations in raw material prices

                                          Government and environmental
Renewable energy based solutions
                                          regulations

Strategic acquisitions and partnerships




                                                                                Liquidity Position

                                                                                The company reported a current ratio of 1.65 in 2010,
                                                                                as compared to its peers, Novozymes A/S, MGP
                                                                                Ingredients, Inc. and Suedzucker AG, which recorded
                                                                                current ratios of 2.21, 2.06 and 1.66 respectively. As
                                                                                of April 2010, the company recorded cash and short-
                                                                                term investments of worth US$124.20 million, against
                                                                                US$307.30 million current debt. The company
                                                                                reported a debt to equity ratio of 0.34 in 2010 as
                                                                                compared to its peers, Novozymes A/S, MGP
                                                                                Ingredients, Inc. and Suedzucker AG, which recorded
                                                                                debt to equity ratios of 0.24, 0.04 and 0.60
                                                                                respectively.




___________________________________________________________________________________________

Danisco A-S - SWOT Profile                                                                                              Page 1
Danisco A-S

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Solvency ..........................................................................................................................................................12
    2.3       Key Competitors ...................................................................................................................................................13
3     Mergers & Acquisitions and Partnerships ........................................................................................... 14
    3.1       M&A and Partnerships Strategy ...........................................................................................................................14
4     Recent Developments ........................................................................................................................... 17
5     SWOT Analysis ...................................................................................................................................... 19
    5.1       SWOT Analysis - Overview ..................................................................................................................................19
    5.2       Strengths ..............................................................................................................................................................19
    5.3       Weaknesses .........................................................................................................................................................19
    5.4       Opportunities ........................................................................................................................................................19
    5.5       Threats .................................................................................................................................................................20
6     Company Statement .............................................................................................................................. 21
7     History .................................................................................................................................................... 23
8     Key Employees ...................................................................................................................................... 26
9     Key Employee Biographies................................................................................................................... 27
10    Locations and Subsidiaries .................................................................................................................. 28
    10.1      Head Office ..........................................................................................................................................................28
    10.2      Other Locations and Subsidiaries ........................................................................................................................28
11    Appendix ................................................................................................................................................ 30
    11.1      Methodology .........................................................................................................................................................30
    11.2      Ratio Definitions ...................................................................................................................................................30
    11.3      Disclaimer.............................................................................................................................................................34




___________________________________________________________________________________________

Danisco A-S - SWOT Profile                                                                                                                                                  Page 2
Danisco A-S

__________________________________________________________________________________________



List of Tables

Table 1: Major Products and Services....................................................................................................................................6
Table 2: Key 
				
DOCUMENT INFO
Description: ICD Research's "Danisco A/S: Alternative Energy Company Profile, SWOT & Financial Report" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, mergers & acquisitions, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.